Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:28 PM
Ignite Modification Date:
2025-12-24 @ 9:28 PM
NCT ID:
NCT07037732
Eligibility Criteria:
Inclusion Criteria:
* Patient who undergo rituximab treatment according to routine care and having one of the following disorder:
* primary immune thrombocytopenia
* primary autoimmune hemolytic anemia
* systmic lupus erythematous
* systemic sclerosis
* rheumatoid arthritis
* inflammatory myopathy
* ANCA associated vasculitis
* Cryoglobulinemic vasculitis
Exclusion Criteria:
* Patients undergoing multiple immunosuppressive drugs because of refractory disease or concomitant hemopathy or malignancy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07037732
Study Brief:
Protocol Section:
NCT07037732